BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2786747)

  • 1. Identification by monoclonal antibody of the tumor antigen of a human autologous breast cancer cell that is involved in cytotoxicity by a cytotoxic T-cell clone.
    Okubo M; Sato N; Wada Y; Takahashi S; Torimoto K; Takahashi N; Sato T; Okazaki M; Asaishi K; Kikuchi K
    Cancer Res; 1989 Jul; 49(14):3950-4. PubMed ID: 2786747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction.
    Kikuchi K; Okubo M; Sato T; Sato N
    Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific cytotoxicity of a long-term cultured T-cell clone on human autologous mammary cancer cells.
    Sato T; Sato N; Takahashi S; Koshiba H; Kikuchi K
    Cancer Res; 1986 Sep; 46(9):4384-9. PubMed ID: 3488124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of n-butyl alcohol solubilized, breast tumor specific antigens recognized by a human autologous cytotoxic T-cell clone.
    Sato T; Sato N; Takahashi S; Okubo M; Yagihashi A; Torigoe T; Takahashi N; Okazaki M; Asaishi K; Kukuchi K
    Cancer Res; 1988 Jul; 48(14):3892-7. PubMed ID: 3260127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a tumor-associated target antigen, ATM-1, for a human T-cell clone with activated killer activity and its existence in sera of cancer patients.
    Kaieda T; Imawari M; Yamasaki Z; Ohnishi S; Koike M; Idezuki Y; Takaku F
    Cancer Res; 1988 Sep; 48(17):4848-54. PubMed ID: 3044579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Pecorelli S; Cannon MJ; Parham GP
    Am J Obstet Gynecol; 2000 Sep; 183(3):601-9. PubMed ID: 10992180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a human T cell clone with the cytotoxic T lymphocyte and natural killer-like cytotoxic function against autologous mammary carcinoma and K562 line.
    Sato T; Okubo M; Wada Y; Sato N; Kikuchi K
    Jpn J Cancer Res; 1989 Jul; 80(7):655-61. PubMed ID: 2507488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
    Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
    Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune response to human sarcomas: cytotoxic T cell clones reactive with autologous sarcomas. I. Development, phenotype, and specificity.
    Slovin SF; Lackman RD; Ferrone S; Kiely PE; Mastrangelo MJ
    J Immunol; 1986 Nov; 137(9):3042-8. PubMed ID: 3093588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.
    Jerome KR; Domenech N; Finn OJ
    J Immunol; 1993 Aug; 151(3):1654-62. PubMed ID: 8393050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S; Wehler T; Schnürer E; Lennerz V; Brenner W; Melchior S; Gröne M; Nonn M; Strand S; Meyer R; Ranieri E; Huber C; Falk CS; Herr W
    Cancer Res; 2006 Dec; 66(23):11447-54. PubMed ID: 17145892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and distribution in normal and tumoral human tissues of breast cancer-associated antigen defined by monoclonal antibody 7B10.
    Pancino GF; Le Doussal V; Mortada MH; Berthon P; Osinaga E; Calvo F; Roseto A
    Cancer Res; 1989 Dec; 49(24 Pt 1):7078-85. PubMed ID: 2555058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel monoclonal antibody (7B10) with differential reactivity between human mammary carcinoma and normal breast.
    Pancino G; Charpin C; Calvo F; Guillemin MC; Roseto A
    Cancer Res; 1987 Aug; 47(16):4444-52. PubMed ID: 3607774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of cytotoxic cells against tumors with heterocrosslinked, bispecific antibodies.
    Segal DM; Qian JH; Garrido MA; Perez P; Winkler DF; Wunderlich JR; Snider DP; Valdayo MJ; Titus JA
    Princess Takamatsu Symp; 1988; 19():323-31. PubMed ID: 3269363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes.
    Rohrer JW; Barsoum AL; Dyess DL; Tucker JA; Coggin JH
    J Immunol; 1999 Jun; 162(11):6880-92. PubMed ID: 10352310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC; Goedegebuure PS; Peoples GE; Rogers SO; Eberlein TJ
    J Immunol; 1995 Nov; 155(9):4486-91. PubMed ID: 7594611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.